Clinical Features and Resistance to Entecavir Monotherapy of Patients with Hepatitis B

AIM: Hepatitis B virus (HBV) infection is a major public health concern worldwide. Entecavir (ETV), a first-line nucleos(t)ide analogue (NA) for HBV, has a low risk of resistance. We evaluated the efficacy of ETV monotherapy, ratio of ETV-resistant, and the clinical features of patients with ETV res...

Descripción completa

Detalles Bibliográficos
Autores principales: Takayama, Hideo, Komura, Takuya, Kagaya, Takashi, Sugimoto, Saiho, Orita, Noriaki, Asahina, Yoshiro, Nishikawa, Masashi, Ohta, Hajime, Kaneko, Shuichi, Unoura, Masashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376438/
https://www.ncbi.nlm.nih.gov/pubmed/34422709
http://dx.doi.org/10.1155/2021/3259833

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8376438/
https://www.ncbi.nlm.nih.gov/pubmed/34422709
http://dx.doi.org/10.1155/2021/3259833

Ejemplares similares